A trial of custirsen with cabazitaxel and prednisolone for prostate cancer that has spread (AFFINITY)

Overview

Cancer types:

Prostate cancer

Status:

Results

Phase:

Phase 3

Details

This trial looked at custirsen with cabazitaxel and prednisolone for men who had prostate cancer that had spread and other treatments were no longer working.

Recruitment start: 9 September 2012

Recruitment end: 29 September 2014

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Karim Fizazi Tomasz Beer Sebastien Hotte

Supported by

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

OncoGenex Pharmaceuticals, Inc

Last reviewed: 22 February 2018

CRUK internal database number: 10725

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.